Institute of Molecular Virology, University Ulm Medical Center, Ulm, Germany.
Laboratory of Experimental Immunology, Institute of Virology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
J Virol. 2024 Apr 16;98(4):e0119023. doi: 10.1128/jvi.01190-23. Epub 2024 Mar 19.
Topically applied microbicides may play a critical role in preventing sexual transmission of human immunodeficiency virus type 1 (HIV-1); however, their efficacy can be compromised by amyloid fibrils present in semen, which significantly increase HIV-1 infectivity. This phenomenon may have contributed to the failure of most microbicide candidates in clinical settings. Understanding the impact of semen on microbicide effectiveness is thus crucial. In our study, we evaluated the influence of semen on the neutralizing activity of broadly neutralizing antibodies (bNAbs), including PG16, PGT121, 10-1074, 3BNC117, and VRC01, which are potential microbicide candidates. We found that semen enhances infection of HIV-1 transmitted/founder viruses but only marginally affects the neutralizing activity of tested antibodies, suggesting their potential for microbicide application. Our findings underscore the need to consider semen-mediated enhancement when evaluating and developing microbicides and highlight the potential of incorporating HIV-1 bNAbs in formulations to enhance efficacy and mitigate HIV-1 transmission during sexual encounters.IMPORTANCEThis study examined the impact of semen on the development of microbicides, substances used to prevent the transmission of HIV-1 during sexual activity. Semen contains certain components that can render the virus more infectious, posing a challenge to microbicide effectiveness. Researchers specifically investigated the effect of semen on a group of powerful antibodies called broadly neutralizing antibodies, which can neutralize a large spectrum of different HIV-1 variants. The results revealed that semen only had a minimal effect on the antibodies' ability to neutralize the virus. This is promising because it suggests that these antibodies could still be effective in microbicides, even in the presence of semen. Understanding this interaction is crucial for developing better strategies to prevent HIV-1 transmission. By incorporating the knowledge gained from this study, scientists can now focus on creating microbicides that consider the impact of semen, bringing us closer to more effective prevention methods.
局部应用的杀微生物剂可能在预防人类免疫缺陷病毒 1 型(HIV-1)的性传播中发挥关键作用;然而,存在于精液中的淀粉样纤维会损害杀微生物剂的功效,从而显著增加 HIV-1 的感染性。这种现象可能导致大多数候选杀微生物剂在临床环境中失败。因此,了解精液对杀微生物剂功效的影响至关重要。在我们的研究中,我们评估了精液对广谱中和抗体(bNAb)中和活性的影响,包括 PG16、PGT121、10-1074、3BNC117 和 VRC01,它们是潜在的杀微生物剂候选物。我们发现,精液增强了 HIV-1 传播/起始病毒的感染,但仅略微影响测试抗体的中和活性,这表明它们有作为杀微生物剂应用的潜力。我们的研究结果强调了在评估和开发杀微生物剂时需要考虑精液介导的增强作用,并突出了在配方中加入 HIV-1 bNAb 以提高功效和减轻性接触中 HIV-1 传播的潜力。
重要性
本研究考察了精液对杀微生物剂发展的影响,杀微生物剂是用于防止性活动中 HIV-1 传播的物质。精液中含有某些成分,可使病毒更具感染力,从而对杀微生物剂的功效构成挑战。研究人员专门研究了精液对一组强大的抗体(称为广谱中和抗体)的影响,这些抗体可以中和大量不同的 HIV-1 变体。结果表明,精液仅对抗体中和病毒的能力产生最小的影响。这是有希望的,因为这表明即使存在精液,这些抗体在杀微生物剂中仍可能有效。了解这种相互作用对于制定更好的预防 HIV-1 传播策略至关重要。通过整合本研究获得的知识,科学家现在可以专注于创建考虑精液影响的杀微生物剂,使我们更接近更有效的预防方法。